E-mail

E-mail a Wiley Online Library Link

Stephanie Duncanson and Athanassios Sambanis Dual factor delivery of CXCL12 and Exendin-4 for improved survival and function of encapsulated beta cells under hypoxic conditions Biotechnology and Bioengineering 110

Version of Record online: 26 MAR 2013 | DOI: 10.1002/bit.24872

Thumbnail image of graphical abstract

A promising treatment for diabetes is a bioartifical pancreas. However, graft failure occurs, in part due to hypoxic conditions at the transplant site. CXCL12 and GLP-1 have been shown to have anti-apoptotic effects on beta cells, and additionally GLP-1 has insulinotropic effects. In this study, the authors found that presentation of CXCL12 in combination with delivery of Exendin-4 (Ex-4), a GLP-1 analog, significantly reduced beta-cell apoptosis and increased insulin secretion under hypoxic conditions.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH